CONSTRUCTION OF A GT POLYMORPHISM MAP OF HUMAN 9Q

被引:163
|
作者
KWIATKOWSKI, DJ
HENSKE, EP
WEIMER, K
OZELIUS, L
GUSELLA, JF
HAINES, J
机构
[1] MASSACHUSETTS GEN HOSP,NEUROGENET LAB,BOSTON,MA 02114
[2] HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115
关键词
D O I
10.1016/0888-7543(92)90370-8
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To construct a framework map of human chromosome 9 consisting of highly informative markers, we identified 36 cosmid clones from chromosome 9 that contained long GT repeat sequences. The cosmids were found to cluster on the long arm of the chromosome, particularly in the q32-34 region. Thirteen highly informative polymorphisms from 9q were identified, with median observed heterozygosity 0.75 and median calculated heterozygosity based upon allele frequencies of 0.75. These new GT repeat polymorphisms (D9S56, D9S58-67), as well as anchor GT polymorphisms for D9S15 (MCT112, 9q13), and ABL and ASS (both 9q34.1) were utilized to construct a linkage map of human 9q by the typing of the Venezuelan Reference Pedigree. Care was taken to avoid errors, including analysis of the data with CHROMLOOK and verification of all double crossover events detected within a 30 cM interval by repetition of the marker analysis. The map was generated using the MAPAKER program. All positions in the resulting map are favored by odds of > 104:1. The map has a sexaveraged length of 90 cM (Kosambi function) with a single maximum intermarker recombination fraction of 26%. All other intermarker recombination fractions are less than 15%. As D9S15 is known to be closely linked to markers on proximal 9p, and ASS ABL are in band 34.1, this set of GT polymorphisms spans the length of 9q and provides a useful panel for linkage analysis of disease genes to this region. The marker order was confirmed by in situ hybridization of the cosmid clones to metaphase spreads of normal human chromosomes, which indicated an excess of recombination in the telomeric region in comparison to centromeric 9q, in agreement with previous chiasmata distribution observations. Two spontaneous new mutations for these GT repeat markers were identified, giving an overall observed spontaneous mutation rate of 0.00045 per locus per gamete. Direct observation of new mutations has not been previously reported for dinucleotide polymorphisms, but the observed rate is consistent with frequencies observed for other VNTR polymorphisms. © 1992.
引用
收藏
页码:229 / 240
页数:12
相关论文
共 50 条
  • [21] JUMPING TRANSLOCATION OF 9Q IN A CASE OF FOLLICULAR LYMPHOMA
    WLODARSKA, I
    MECUCCI, C
    DEWOLFPEETERS, C
    VERHOEF, G
    WEIER, HU
    CASSIMAN, JJ
    VANDENBERGHE, H
    CANCER GENETICS AND CYTOGENETICS, 1994, 76 (02) : 140 - 144
  • [22] An association with hypopituitarism and 9q subtelomere deletion syndrome
    Higuchi, Shinji
    Takagi, Masaki
    Takeda, Ryojun
    Yoshihashi, Hiroshi
    Narumi, Satoshi
    Hasegawa, Tomonobu
    CLINICAL CASE REPORTS, 2018, 6 (12): : 2371 - 2375
  • [23] 9q Subtelomeric Deletion Syndrome With Diaphragmatic Hernia
    Klitten, Laura L.
    Tommerup, Niels
    Hjalgrim, Helle
    Moller, Rikke S.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2009, 149A (05) : 1086 - 1088
  • [24] Clinical findings in cases with 9q deletion encompassing the 9q21.11q21.32 region
    Tug, Esra
    Ergun, M. Ali
    Percin, E. Ferda
    TURKISH JOURNAL OF PEDIATRICS, 2018, 60 (01) : 94 - 98
  • [25] Partial trisomy 9q syndrome with a de novo tandem duplication of 9q22.2-q31.1
    Utine, GE
    Melotte, C
    Vermeesch, JR
    Fryns, JP
    GENETIC COUNSELING, 2005, 16 (04): : 407 - 412
  • [26] Cloning and characterization of a putative human D-2-hydroxyacid dehydrogenase in chromosome 9q
    Huang, TS
    Yang, WX
    Pereira, AC
    Craigen, WJ
    Shih, VE
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 268 (02) : 298 - 301
  • [27] Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer
    Hill, S
    Hirao, T
    Marsit, CJ
    Hirao, Y
    Schned, A
    Devi-Ashok, T
    Nelson, HH
    Andrew, A
    Karagas, MR
    Kelsey, KT
    CANCER, 2005, 104 (09) : 1918 - 1923
  • [28] A PATIENT WITH 9q SUBTELOMERIC DELETION SYNDROME WITH ADDITIONAL FINDINGS
    Tug, E.
    Cavdarli, B.
    Karaoguz, M. Yirmibes
    Percin, F. E.
    GENETIC COUNSELING, 2012, 23 (04): : 465 - 471
  • [29] Subtelomeric deletions of chromosome 9q:: A novel microdeletion syndrome
    Stewart, DR
    Huang, A
    Faravelli, F
    Anderlid, BM
    Medne, L
    Ciprero, K
    Kaur, M
    Rossi, E
    Tenconi, R
    Nordenskjöld, M
    Gripp, KW
    Nicholson, L
    Meschino, WS
    Capua, E
    Quarrell, OWJ
    Flint, J
    Irons, M
    Giampietro, PF
    Schowalter, DB
    Zaleski, CA
    Malacarne, M
    Zackai, EH
    Spinner, NB
    Krantz, ID
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 128A (04) : 340 - 351
  • [30] Panic disorder and anxiety linked to chromosome 9q in Iceland
    Thorgeirsson, TE
    Oskarsson, H
    Desnica, N
    Kostic, JP
    Stefansson, JG
    Kolbeinsson, H
    Lindal, E
    Gagunashvili, N
    Frigge, ML
    Kong, A
    Stefansson, K
    Gulcher, JR
    NORDIC JOURNAL OF PSYCHIATRY, 2003, 57 (02) : 109 - 109